MHRA Approves Two Phase 2 Clinical Trials of ‘1805 in Autoimmune Diseases in UK
According to a recent article, Revolo Biotherapeutics announced it has obtained approval from the Medicines and Healthcare products Regulatory Agency (MHRA) for two Phase 2 clinical trials to analyze its…